BRPI0918641A8 - Produtos infantis pró-bióticos. - Google Patents

Produtos infantis pró-bióticos.

Info

Publication number
BRPI0918641A8
BRPI0918641A8 BRPI0918641A BRPI0918641A BRPI0918641A8 BR PI0918641 A8 BRPI0918641 A8 BR PI0918641A8 BR PI0918641 A BRPI0918641 A BR PI0918641A BR PI0918641 A BRPI0918641 A BR PI0918641A BR PI0918641 A8 BRPI0918641 A8 BR PI0918641A8
Authority
BR
Brazil
Prior art keywords
infant products
probiotic
infant
probiotic infant
source
Prior art date
Application number
BRPI0918641A
Other languages
English (en)
Inventor
Michael Russell William
Ceddia Michael
Original Assignee
Mjn U S Holding Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn U S Holding Llc filed Critical Mjn U S Holding Llc
Publication of BRPI0918641A2 publication Critical patent/BRPI0918641A2/pt
Publication of BRPI0918641A8 publication Critical patent/BRPI0918641A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PRODUTOS INFANTIS PRÓ-BIÓTICOS. A presente invenção refere-se a uma fórmula infantil ou produto nutricional de crianças que compreende uma fonte de proteína, uma fonte de gordura, uma fonte de carboidrato, e B. longum AH1205.
BRPI0918641A 2008-09-19 2009-09-18 Produtos infantis pró-bióticos. BRPI0918641A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/284,230 US8137718B2 (en) 2008-09-19 2008-09-19 Probiotic infant products
PCT/US2009/057426 WO2010033768A1 (en) 2008-09-19 2009-09-18 Probiotic infant products

Publications (2)

Publication Number Publication Date
BRPI0918641A2 BRPI0918641A2 (pt) 2015-08-25
BRPI0918641A8 true BRPI0918641A8 (pt) 2016-04-12

Family

ID=42037894

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918641A BRPI0918641A8 (pt) 2008-09-19 2009-09-18 Produtos infantis pró-bióticos.

Country Status (15)

Country Link
US (1) US8137718B2 (pt)
EP (1) EP2323494B8 (pt)
CN (1) CN102159085B (pt)
BR (1) BRPI0918641A8 (pt)
CA (1) CA2737655A1 (pt)
CO (2) CO6351696A2 (pt)
CZ (1) CZ2011140A3 (pt)
ES (1) ES2398188T3 (pt)
MX (1) MX2011002239A (pt)
NO (1) NO20110169A1 (pt)
PE (1) PE20110932A1 (pt)
PL (1) PL2323494T3 (pt)
RU (1) RU2011115226A (pt)
TW (1) TW201026239A (pt)
WO (1) WO2010033768A1 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0809448A2 (pt) * 2007-03-28 2014-09-09 Alimentary Health Ltd Cepas de bifidobacterium probióticas
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
US20110223137A1 (en) * 2008-12-05 2011-09-15 Nestec S.A. Compositions for use in low-birth weight infants
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
US20120135103A1 (en) * 2010-11-30 2012-05-31 Mead Johnson Nutrition Company Staged Infant Feeding Regimen To Promote Healthy Development And Growth
US9375028B2 (en) * 2010-12-09 2016-06-28 Mead Johnson Nutrition Company Compositions and methods for nutrient delivery
US20130280225A1 (en) * 2010-12-29 2013-10-24 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
US20120171164A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
TR201109721A2 (tr) 2011-09-30 2012-03-21 Spi̇l Teknoloji̇ Bi̇li̇şi̇m İnternet Ve Web Tasarim Hi̇zmetleri̇ Özel Eği̇ti̇m Öğreti̇m Kurumlari Ve Danişmanlik Elektri̇k Elektroni̇k İnşaat Gida İmalat İthalat İhracat San. Ve Ti̇c. Ltd. Şti̇. Zeytinli bebek ek besini.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9474298B2 (en) * 2011-10-11 2016-10-25 Mead Johnson Nutrition Company Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20140242216A1 (en) * 2013-02-24 2014-08-28 Mead Johnson Nutrition Company Amino Acid And Protein Hydrolysate Based Formulas With A Stable Emulsion System
US20140271979A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Anti-regurgitation nutritional composition
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
WO2014200334A1 (en) 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
CN103820357A (zh) * 2013-12-30 2014-05-28 上海交大昂立股份有限公司 一株长双歧杆菌及其防治食物过敏的功能
SG11201607831TA (en) 2014-03-26 2016-10-28 Abbott Lab Nutritional supplement powder
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN105112333A (zh) * 2015-08-31 2015-12-02 江南大学 一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108472274B (zh) * 2016-01-26 2025-08-19 雀巢产品有限公司 用于预防或减少经皮水分流失的组合物
CN108697139A (zh) 2016-02-29 2018-10-23 雅培制药有限公司 营养补充粉
ME03487B (me) 2016-03-04 2020-01-20 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
WO2019090093A1 (en) * 2017-11-03 2019-05-09 Advanced Bionutrition Corp. Composition containing viable microorganisms and methods of making
FR3078609B1 (fr) * 2018-03-08 2020-02-21 Abcd Nutrition Composition pour diminuer la sensibilite au gluten
FR3078610B1 (fr) * 2018-03-08 2020-02-21 Abcd Nutrition Composition de probiotiques particuliers et utilisation pour diminuer les symptomes inflammatoires digestifs
EP4451918B1 (en) * 2021-12-20 2026-02-25 Société des Produits Nestlé S.A. Secretory iga-biotic complexes and uses thereof
CN114276961A (zh) * 2021-12-30 2022-04-05 光明乳业股份有限公司 一种长双歧杆菌婴儿亚种ccfm1192菌株、发酵剂及其制备方法与应用
CN120000694A (zh) * 2025-02-24 2025-05-16 合生元（广州）健康产品有限公司 一种用于缓解呼吸道不适的组合物及其应用和产品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843698A (en) * 1997-04-30 1998-12-01 Universal Ventures Deleteriously affecting members of a target species by exposure to a component of symbiont or food source of an adjoiner species that is symbiotic with the target species
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
US6074815A (en) * 1999-03-08 2000-06-13 Universal Ventures Selection of test species for testing to identify components thereof that deleteriously affect a target species member
US6150127A (en) * 1999-11-30 2000-11-21 Universal Ventures Causing a desirable change in a behavior pattern
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
BRPI0809448A2 (pt) 2007-03-28 2014-09-09 Alimentary Health Ltd Cepas de bifidobacterium probióticas

Also Published As

Publication number Publication date
CO6351695A2 (es) 2011-12-20
TW201026239A (en) 2010-07-16
EP2323494A1 (en) 2011-05-25
RU2011115226A (ru) 2012-10-27
EP2323494A4 (en) 2011-11-02
BRPI0918641A2 (pt) 2015-08-25
CO6351696A2 (es) 2011-12-20
US20100074871A1 (en) 2010-03-25
HK1160729A1 (en) 2012-08-17
WO2010033768A1 (en) 2010-03-25
NO20110169A1 (no) 2011-03-30
US8137718B2 (en) 2012-03-20
CZ2011140A3 (cs) 2011-09-07
ES2398188T3 (es) 2013-03-14
EP2323494B1 (en) 2012-10-24
PL2323494T3 (pl) 2013-03-29
EP2323494B8 (en) 2012-12-26
CN102159085B (zh) 2013-10-02
CN102159085A (zh) 2011-08-17
MX2011002239A (es) 2011-04-05
CA2737655A1 (en) 2010-03-25
PE20110932A1 (es) 2012-01-29

Similar Documents

Publication Publication Date Title
BRPI0918641A8 (pt) Produtos infantis pró-bióticos.
BR132020021160E2 (pt) composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo
BR112014030434A2 (pt) método não terapêutico; uso de uma proteína; composição nutricional; e uso da composição nutricional
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
BR112012003633A2 (pt) "composição nutricional que compreende cepas de bifidobacterium longum e reduz os sintomas de alergia alimentar, especialmente em bebês e crianças."
UY33405A (es) Composiciones y bebidas que comprenden nutrientes, vitaminas, azúcares, cisteína y/o productos de azúcar-cisteína
BR112015023484A2 (pt) composição de carboidrato, produto e processso para preparar uma composição de carboidrato
BR112013028705A2 (pt) cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes
EP2323493B8 (en) Probiotic infant products
IN2015DN03862A (pt)
MY169265A (en) Obesity animal model and methods for making and using thereof
BR112017002627A2 (pt) prebióticos para reduzir o risco de obesidade no futuro
BR112012023328A2 (pt) composições nutricionais
BR112012026906A2 (pt) método para obtenção de produtos nutritivos à base de leguminosas
PH12017500498A1 (en) Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
BR112017023636A2 (pt) suplemento dietético
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
AR083093A1 (es) Combinacion para reemplazo de grasas para la sustitucion parcial o total de la grasa en productos alimenticios y un producto alimenticio que la contiene
WO2014033574A3 (en) Protein stabilized probiotics and personal care products
BR112012020064A2 (pt) produto de leite e método de produzir o referido produto
BR112012011314A2 (pt) glicosil transferase de hamster chinês e métodos relacionados
MX2010000434A (es) Metodos demostrativos para productos de papel higienico.
BR112013006702A2 (pt) nutrição de laticíneos com cereais
RU2010121553A (ru) Штамм bifidobacterium bifidum 74-23, используемый для получения бифидосодержащей продукции

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25A Requested transfer of rights approved

Owner name: MEAD JOHNSON NUTRITION COMPANY (US)